Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,405 | 136 | 46.2% |
| Honoraria | $4,500 | 4 | 28.1% |
| Consulting Fee | $3,950 | 2 | 24.6% |
| Travel and Lodging | $172.94 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aries Pharmaceuticals, Inc. | $5,100 | 10 | $0 (2018) |
| Medivators Inc. | $3,798 | 2 | $0 (2021) |
| Boston Scientific Corporation | $1,411 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $769.37 | 16 | $0 (2023) |
| PENTAX of America, Inc. | $658.13 | 9 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $657.36 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $610.61 | 5 | $0 (2021) |
| Allergan, Inc. | $580.74 | 16 | $0 (2020) |
| Olympus America Inc. | $398.41 | 3 | $0 (2021) |
| ABBVIE INC. | $378.51 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $730.53 | 6 | Boston Scientific Corporation ($476.73) |
| 2023 | $251.31 | 5 | PENTAX of America, Inc. ($125.39) |
| 2022 | $257.84 | 8 | Ironwood Pharmaceuticals, Inc ($94.96) |
| 2021 | $5,000 | 16 | Medivators Inc. ($3,750) |
| 2020 | $425.68 | 16 | QOL Medical, LLC ($137.96) |
| 2019 | $1,660 | 31 | Allergan Inc. ($331.17) |
| 2018 | $3,255 | 18 | Aries Pharmaceuticals, Inc. ($2,311) |
| 2017 | $4,448 | 43 | Aries Pharmaceuticals, Inc. ($2,788) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boston Scientific Corporation | — | Travel and Lodging | Cash or cash equivalent | $172.94 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/12/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: AMS 700_URO | ||||||
| 09/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $132.23 | General |
| 08/07/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Acquire_ENDO | ||||||
| 05/18/2024 | PENTAX of America, Inc. | INSPIRA (Device), PENTAX Medical, PENTAX Medical | Food and Beverage | Cash or cash equivalent | $253.80 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $159.73 | General |
| Category: General - Hemostasis_ENDO | ||||||
| 12/14/2023 | PENTAX of America, Inc. | Aloka Arietta 850 (Device) | Food and Beverage | Cash or cash equivalent | $125.39 | General |
| Category: Gastroenterology | ||||||
| 12/14/2023 | Micro-tech Endoscopy USA, Inc. | EndoRotor (Device) | Food and Beverage | Cash or cash equivalent | $62.81 | General |
| Category: GI Endoscopy | ||||||
| 10/19/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $28.31 | General |
| 02/15/2023 | AXOGEN | Avance Nerve Graft (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Neurology | ||||||
| 09/13/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $94.96 | General |
| Category: GI | ||||||
| 09/02/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/23/2022 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Medical Device | ||||||
| 08/04/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/15/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Neuroscience | ||||||
| 04/07/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2021 | Olympus America Inc. | VISIGLIDE (Device) | Food and Beverage | In-kind items and services | $144.77 | General |
| Category: Endotherapy | ||||||
| 11/18/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $121.40 | General |
| Category: Neuroscience | ||||||
| 10/31/2021 | Medivators Inc. | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 10/12/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 286 | 297 | $406,377 | $38,195 |
| 2022 | 11 | 299 | 320 | $402,279 | $39,552 |
| 2021 | 12 | 441 | 495 | $456,999 | $54,199 |
| 2020 | 9 | 223 | 236 | $278,481 | $28,402 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 59 | $40,651 | $6,206 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $37,597 | $5,838 | 15.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 26 | 26 | $70,694 | $5,566 | 7.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 24 | $23,496 | $3,529 | 15.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $60,575 | $3,215 | 5.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 35 | $62,860 | $2,984 | 4.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $28,602 | $2,958 | 10.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $34,731 | $2,781 | 8.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 16 | $9,344 | $1,846 | 19.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 15 | $23,685 | $1,379 | 5.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $8,708 | $984.54 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $5,434 | $907.17 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $51,352 | $8,041 | 15.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $81,570 | $6,772 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 43 | $29,627 | $5,030 | 17.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $64,656 | $3,344 | 5.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $46,989 | $3,300 | 7.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $15,730 | $2,994 | 19.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $53,306 | $2,766 | 5.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 40 | $12,880 | $2,560 | 19.9% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2022 | 12 | 12 | $13,824 | $2,039 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $11,818 | $1,461 | 12.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $20,527 | $1,245 | 6.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $41,216 | $8,513 | 20.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 29 | 29 | $78,851 | $7,093 | 9.0% |
About Dr. David Robbins, MD
Dr. David Robbins, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1124003090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Robbins, MD has received a total of $16,028 in payments from pharmaceutical and medical device companies, with $730.53 received in 2024. These payments were reported across 143 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,405).
As a Medicare-enrolled provider, Robbins has provided services to 1,249 Medicare beneficiaries, totaling 1,348 services with total Medicare billing of $160,348. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 12/13/2005
- Last Updated 10/29/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1124003090
Products in Payments
- ELEVIEW (Device) $5,100
- DIFICID (Drug) $723.99
- ZEPOSIA (Drug) $634.64
- ESD - Core Endoscopy (Device) $394.97
- LINZESS (Drug) $383.60
- GENERAL - THERAPIES (Device) $361.56
- VIBERZI (Drug) $322.14
- ESD - EUS (Device) $262.39
- INSPIRA (Device) $253.80
- Olympus Biliary Devices (Device) $253.64
- Sucraid (Drug) $197.25
- SureClip and Traction Device (Device) $169.50
- Humira (Biological) $159.38
- VISIGLIDE (Device) $144.77
- SPYSCOPE (Device) $140.54
- Aloka Arietta 850 (Device) $125.39
- LINX Reflux Management System (Device) $124.99
- GI Genius (Device) $124.57
- Beacon (Device) $121.30
- GENERAL POLYPECTOMY (Device) $120.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554